These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27122276)

  • 1. Warfarin continuation vs interruption during procedures of cardiac rhythm devices: A Meta-analysis of randomized controlled trials.
    Sun H; Du B; Liu X; Yang S; Yang P
    J Pak Med Assoc; 2016 Apr; 66(4):458-65. PubMed ID: 27122276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.
    Ghanbari H; Feldman D; Schmidt M; Ottino J; Machado C; Akoum N; Wall TS; Daccarett M
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):400-6. PubMed ID: 20180915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.
    Du L; Zhang Y; Wang W; Hou Y
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1573-86. PubMed ID: 25234639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation.
    Thal S; Moukabary T; Boyella R; Shanmugasundaram M; Pierce MK; Thai H; Goldman S
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):385-8. PubMed ID: 20059711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure.
    Li HK; Chen FC; Rea RF; Asirvatham SJ; Powell BD; Friedman PA; Shen WK; Brady PA; Bradley DJ; Lee HC; Hodge DO; Slusser JP; Hayes DL; Cha YM
    Pacing Clin Electrophysiol; 2011 Jul; 34(7):868-74. PubMed ID: 21410724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Perioperative Anticoagulation for Device Implantation.
    Stewart MH; Morin DP
    Card Electrophysiol Clin; 2018 Mar; 10(1):99-109. PubMed ID: 29428146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial.
    Cheng A; Nazarian S; Brinker JA; Tompkins C; Spragg DD; Leng CT; Halperin H; Tandri H; Sinha SK; Marine JE; Calkins H; Tomaselli GF; Berger RD; Henrikson CA
    Heart Rhythm; 2011 Apr; 8(4):536-40. PubMed ID: 21147261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implanting cardiac rhythm devices during uninterrupted warfarin therapy: a prospective, single center experience.
    Crosato M; Calzolari V; Franceschini Grisolia E; Daniotti A; Baldessin F; Mantovan R; Olivari Z
    J Cardiovasc Med (Hagerstown); 2015 Jul; 16(7):503-6. PubMed ID: 25022924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periprocedural bridging anticoagulation: current perspectives.
    Palaniswamy C; Selvaraj DR
    Am J Ther; 2011 Jul; 18(4):e89-94. PubMed ID: 20228672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pacemaker or defibrillator surgery without interruption of anticoagulation.
    Birnie DH; Healey JS; Wells GA; Verma A; Tang AS; Krahn AD; Simpson CS; Ayala-Paredes F; Coutu B; Leiria TL; Essebag V;
    N Engl J Med; 2013 May; 368(22):2084-93. PubMed ID: 23659733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices.
    Ghanbari H; Phard WS; Al-Ameri H; Latchamsetty R; Jongnarngsin K; Crawford T; Good E; Chugh A; Oral H; Bogun F; Morady F; Pelosi F
    Am J Cardiol; 2012 Nov; 110(10):1482-8. PubMed ID: 22906894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
    Ahmed I; Gertner E; Nelson WB; House CM; Dahiya R; Anderson CP; Benditt DG; Zhu DW
    Heart Rhythm; 2010 Jun; 7(6):745-9. PubMed ID: 20176137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies.
    Proietti R; Porto I; Levi M; Leo A; Russo V; Kalfon E; Biondi-Zoccai G; Roux JF; Birnie DH; Essebag V
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1461-79. PubMed ID: 25967723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
    Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
    J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative management of antithrombotic therapy in patients receiving cardiovascular implantable electronic devices: a network meta-analysis.
    He H; Ke BB; Li Y; Han FS; Li X; Zeng YJ
    J Interv Card Electrophysiol; 2017 Oct; 50(1):65-83. PubMed ID: 28842832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantation of cardiac rhythm devices during concomitant anticoagulation or antiplatelet therapy.
    Ramirez A; Wall TS; Schmidt M; Selzman K; Daccarett M
    Expert Rev Cardiovasc Ther; 2011 May; 9(5):609-14. PubMed ID: 21615324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of thromboembolism with short-term interruption of warfarin therapy.
    Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
    Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
    Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
    Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
    Chen HC; Chen YL; Guo BF; Tsai TH; Chang JP; Pan KL; Lin YS; Chen MC
    Can J Cardiol; 2013 Sep; 29(9):1110-7. PubMed ID: 23474139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.
    Jamula E; Douketis JD; Schulman S
    J Thromb Haemost; 2008 Oct; 6(10):1615-21. PubMed ID: 18638011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.